OpenVSafe by OpenVAERS
Search V-safe

FHM-28919-78508

3 vaccinations 5 coded responses 28 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
750 / TX
Registered
2021-01-04
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1753929 (opens in a new window) high 11 / 11 — 1 of 1 VAERS symptoms same dose (3) TX matches 2021-08-16 / 2021-08-26 / 2021-10-01
received 320 days before the last call
case 942188

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-01-04
    Registered in v-safe
  2. 2021-01-04
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-04
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-01-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-01-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-11
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-18
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-01-25
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-25
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-01-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  17. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-02-08
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-22
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-03-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-26
    Survey response — 6 months, dose 2
    MedDRA: Epistaxis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Nosebleeds (x4). Never had one before.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  28. 2021-07-26
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-08-16
    Dose 3 — Pfizer-BioNTech
  30. 2021-09-29
    Survey response — day 42, dose 3
    MedDRA: Extrasystoles, Pre-existing disease, Supraventricular extrasystoles, Ventricular extrasystoles — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Frequent PACs and PVCs that started about 10 days after the third dose. Currently on a two week heart monitor to diagnose. I have two preexisting heart conditions, but not excessive premature beats.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-09-29
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2021-10-01
    Call successful
    Completed over the phone
  33. 2021-10-01
    Call successful
    Completed over the phone
  34. 2021-11-15
    Survey response — 3 months, dose 3
    MedDRA: Epstein-Barr virus infection, Infectious mononucleosis — Feeling: Fair · Be unable to work or attend school
    Free text: Contracted Epstein Barr mononucleosis.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-02-14
    Survey response — 6 months, dose 3
    MedDRA: Epstein-Barr virus infection, Gallbladder operation, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Epstein Barr Mono, chronic acalculus cholecystitis. · Healthcare visit (other): Gallbladder surgery
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-02-14
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  37. 2022-02-15
  38. 2022-08-16
    Survey response — 12 months, dose 3
    MedDRA: Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Stage 4 breast cancer. Original diagnosis in October 2017 as stage 2b
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-08-16
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  40. 2022-08-17
  41. 2022-08-17
  42. 2022-08-17
  43. 2022-08-17

Vaccinations

DoseDateManufacturerCo-administered
12021-01-04Pfizer-BioNTech
22021-01-25Pfizer-BioNTech
32021-08-16Pfizer-BioNTech No

Call center

4 call center cases

2 successful · 2 unsuccessful

VAERS report filed, before or during a call: 3

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-26

Symptoms: Nosebleeds (x4). Never had one before.

Release 9 — day 42, dose 3

2021-09-29

Symptoms: Frequent PACs and PVCs that started about 10 days after the third dose. Currently on a two week heart monitor to diagnose. I have two preexisting heart conditions, but not excessive premature beats.

Release 10 — 3 months, dose 3

2021-11-15

Symptoms: Contracted Epstein Barr mononucleosis.

Release 11 — 6 months, dose 3

2022-02-14

Symptoms: Epstein Barr Mono, chronic acalculus cholecystitis.
Healthcare visit (other): Gallbladder surgery

Release 12 — 12 months, dose 3

2022-08-16

Symptoms: Stage 4 breast cancer. Original diagnosis in October 2017 as stage 2b

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOGallbladder operation · · ✓
SDEpistaxis ✓ · ✓
SDEpstein-Barr virus infection · · ✓
SDExtrasystoles · · ✓
SDInfectious mononucleosis · · ✓
SDPre-existing disease · · ✓
SDSupraventricular extrasystoles · · ✓
SDVentricular extrasystoles · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release